Orrstown Financial Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-74
Closed -$10K 187
2019
Q3
$10K Hold
74
0.01% 188
2019
Q2
$9K Hold
74
0.01% 178
2019
Q1
$8K Hold
74
0.01% 188
2018
Q4
$8K Hold
74
0.01% 176
2018
Q3
$9K Sell
74
-37
-33% -$4.05K 0.01% 183
2018
Q2
$11K Sell
111
-61
-35% -$6.17K 0.01% 208
2018
Q1
$17K Buy
172
+85
+98% +$8.03K 0.02% 203
2017
Q4
$7K Sell
87
-130
-60% -$10.7K 0.01% 244
2017
Q3
$17K Buy
217
+167
+334% +$12.8K 0.02% 210
2017
Q2
$4K Buy
50
+30
+150% +$2.15K ﹤0.01% 244
2017
Q1
$1K Sell
20
-45
-69% -$3.11K ﹤0.01% 250
2016
Q4
$4K Hold
65
﹤0.01% 231
2016
Q3
$4K Buy
65
+45
+225% +$3K ﹤0.01% 226
2016
Q2
$1K Buy
+20
New +$1.18K ﹤0.01% 271

Other funds holding RMD

Orrstown Financial Services's RMD Position: Q4 2019 in Review

Orrstown Financial Services sold out of ResMed (RMD) in Q4 2019, closing a stake of 74 shares — an estimated $10K sold.

Orrstown Financial Services first reported a position in RMD in Q2 2016 and held it in 14 quarters. The position peaked at $17K in Q1 2018. 559 funds tracked by Wall St. Rank hold RMD as of Q4 2019.

  • Orrstown Financial Services reported no remaining ResMed position as of Q4 2019 after selling out during the quarter.
  • Orrstown Financial Services sold 74 ResMed shares in Q4 2019, an estimated $10K.
  • Orrstown Financial Services first reported a position in ResMed in Q2 2016 and held it in 14 quarters.
  • Orrstown Financial Services's ResMed position peaked at $17K in Q1 2018.
  • 559 funds tracked by Wall St. Rank held ResMed as of Q4 2019.

Based on Orrstown Financial Services's 13F filing for Q4 2019, filed 17 Jan 2020.